161 related articles for article (PubMed ID: 32387752)
1. Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.
Yang M; Pan H; Chen H; Liu W; Lu L; He X; Yi H; Tang S
Infect Genet Evol; 2020 Sep; 83():104349. PubMed ID: 32387752
[TBL] [Abstract][Full Text] [Related]
2. NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis.
Yang M; Qiu Y; Jin Y; Liu W; Wang Q; Yi H; Tang S
Pharmacol Res Perspect; 2020 Dec; 8(6):e00696. PubMed ID: 33300686
[TBL] [Abstract][Full Text] [Related]
3. A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.
Zhu J; Liu W; Zhang M; Lu L; Pan H; He X; Wang N; Yang M; Yi H; Tang S
J Clin Pharm Ther; 2021 Oct; 46(5):1288-1294. PubMed ID: 34046917
[TBL] [Abstract][Full Text] [Related]
4. The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort.
Zhang H; Qian H; Tao B; Yang M; Gong J; Yi H; Tang S
Infect Genet Evol; 2018 Dec; 66():217-221. PubMed ID: 30316884
[TBL] [Abstract][Full Text] [Related]
5. Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity.
Wang Y; Xiang X; Huang WW; Sandford AJ; Wu SQ; Zhang MM; Wang MG; Chen G; He JQ
Sci Rep; 2019 Feb; 9(1):2217. PubMed ID: 30778091
[TBL] [Abstract][Full Text] [Related]
6. Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population.
Lu L; Tao B; Wei H; Chen H; He X; Pan H; Yang M; Yi H; Tang S
J Gene Med; 2019 Jun; 21(6):e3096. PubMed ID: 31066138
[TBL] [Abstract][Full Text] [Related]
7. Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study.
Yang M; Zhang H; Tao B; Pan H; Lu L; Yi H; Tang S
J Clin Pharm Ther; 2019 Aug; 44(4):534-542. PubMed ID: 30776144
[TBL] [Abstract][Full Text] [Related]
8. CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
Chen R; Wang J; Tang SW; Zhang Y; Lv XZ; Wu SS; Yang ZR; Xia YY; Chen DF; Zhan SY
Int J Tuberc Lung Dis; 2016 Jun; 20(6):812-8. PubMed ID: 27155186
[TBL] [Abstract][Full Text] [Related]
9. Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.
Sun Q; Liu HP; Zheng RJ; Wang P; Liu ZB; Sha W; Xiao HP
Clin Drug Investig; 2017 Dec; 37(12):1125-1136. PubMed ID: 28900877
[TBL] [Abstract][Full Text] [Related]
10. Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population.
Pan H; Yang M; Lu L; Tao B; He X; Chen H; Yi H; Tang S
Pharmacogenet Genomics; 2019 Jun; 29(4):84-90. PubMed ID: 30720667
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.
Zhang J; Zhao Z; Bai H; Wang M; Jiao L; Peng W; Wu T; Liu T; Chen H; Song X; Wu L; Hu X; Wu Q; Zhou J; Song J; Lyv M; Ying B
PLoS One; 2019; 14(9):e0222033. PubMed ID: 31490979
[TBL] [Abstract][Full Text] [Related]
12. The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury.
Zhang M; Zhu J; Wang N; Liu W; Lu L; Pan H; He X; Yi H; Tang S
J Clin Pharm Ther; 2022 Aug; 47(8):1276-1283. PubMed ID: 35470464
[TBL] [Abstract][Full Text] [Related]
13. Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.
Wang Y; Xiang X; Wu SQ; Chen G; Zhang MM; Wang MG; Wang FJ; Sandford AJ; He JQ
Infect Genet Evol; 2017 Jul; 51():198-202. PubMed ID: 28389387
[TBL] [Abstract][Full Text] [Related]
14. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.
Tang SW; Lv XZ; Zhang Y; Wu SS; Yang ZR; Xia YY; Tu DH; Deng PY; Ma Y; Chen DF; Zhan SY
J Clin Pharm Ther; 2012 Oct; 37(5):588-93. PubMed ID: 22335459
[TBL] [Abstract][Full Text] [Related]
15. NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population.
Lv X; Tang S; Xia Y; Zhang Y; Wu S; Yang Z; Li X; Tu D; Chen Y; Deng P; Ma Y; Chen D; Chen R; Zhan S
Ann Hepatol; 2012; 11(5):700-7. PubMed ID: 22947533
[TBL] [Abstract][Full Text] [Related]
16. Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method.
Chen X; Hao Z; Pan H; Liu W; Lu L; Zhang M; He X; Yi H; Tang S
Fundam Clin Pharmacol; 2023 Aug; 37(4):858-867. PubMed ID: 36855016
[TBL] [Abstract][Full Text] [Related]
17. Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.
Ji GY; Wang Y; Wu SQ; Liu QQ; Wu JC; Zhang MM; Sandford AJ; He JQ
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706680
[TBL] [Abstract][Full Text] [Related]
18. Relevance of gene polymorphisms of NAT2 and NR1I2 to anti-tuberculosis drug-induced hepatotoxicity.
Wang N; Guo S; Liu H; Ding Y; Yao R; Liu Z; Zhu H; Chen X; Yang X; Chen X; Lu Y
Xenobiotica; 2022 May; 52(5):520-526. PubMed ID: 35723590
[TBL] [Abstract][Full Text] [Related]
19. rs1800796 of the IL6 gene is associated with increased risk for anti-tuberculosis drug-induced hepatotoxicity in Chinese Han children.
Li Y; Tang H; Qi H; Shen C; Sun L; Li J; Xu F; Jiao W; Yang X; Shen A
Tuberculosis (Edinb); 2018 Jul; 111():71-77. PubMed ID: 30029918
[TBL] [Abstract][Full Text] [Related]
20. Association of
Wang N; Chen X; Hao Z; Yi H; Tang S
Xenobiotica; 2022 May; 52(5):527-533. PubMed ID: 35735268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
